⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Global Orphan Drugs Market Size, Share and Trends Analysis Report, 2026-2033 | Market to Reach USD 434.9 Billion as Gene and Cell Therapies Drive 9.0% CAGR
globenewswire.com
JNJ
AZN
NVS
VRTX
SNY
AMGN
MRK
BMY
PFE
Gabelli To Host 8th Annual Healthcare Symposium
globenewswire.com
LEGN
GILD
AZN
MCK
LLY
COR
UNH
TDOC
INNV
HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
globenewswire.com
HCM
AZN
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
businesswire.com
AZN
TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
businesswire.com
AZN
IMFINZI ® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
businesswire.com
AZN
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
businesswire.com
AZN
PAK BioSolutions and iBET Advance Integrated Continuous AAV8 Purification
prnewswire.com
AZN
Every Lung Cancer Journey is Unique: American Lung Association Campaign Helps People Find Trusted Information
prnewswire.com
LLY
MRK
AZN
Metastatic HR+/HER2- Breast Cancer - Market Insights, Epidemiology, Competitive Landscape, and Market Forecast - 2036 | 8% CAGR Fueled by Oral SERDs, ADCs, and Targeted Therapies
globenewswire.com
PFE
LLY
AZN
GILD
MRK
ARVN
OMER
CELC
BNTX